Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma. | Int J Gen Med | 2022 | 35282644 | PubTator, text mining | PubMed |
| Common Variation in EDN1 Regulatory Regions Highlights the Role of PPARγ as a Key Regulator of Endothelin in vitro. | Front Cardiovasc Med | 2022 | 35282351 | PubTator, text mining | PubMed |
| The expression of HOXC10 is correlated with tumor-infiltrating immune cells in basal-like breast cancer and serves as a prognostic biomarker. | Ann Transl Med | 2022 | 35282072 | PubTator, text mining | PubMed |
| Comprehensive Transcriptome Analysis of Patients With Keratoconus Highlights the Regulation of Immune Responses and Inflammatory Processes. | Front Genet | 2022 | 35281826 | PubTator, text mining | PubMed |
| The Prognostic Value of GNG7 in Colorectal Cancer and Its Relationship With Immune Infiltration. | Front Genet | 2022 | 35281820 | PubTator, text mining | PubMed |
| Profound gene expression changes in the epithelial monolayer of active ulcerative colitis and Crohn's disease. | PLoS One | 2022 | 35275975 | PubTator, text mining | PubMed |
| LIMK2 Is a Novel Prognostic Biomarker and Correlates With Tumor Immune Cell Infiltration in Lung Squamous Cell Carcinoma. | Front Immunol | 2022 | 35273591 | PubTator, text mining | PubMed |
| Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA). | BMJ Open | 2022 | 35273064 | PubTator, text mining | PubMed |
| Characterization of immune-related genes andimmune infiltration features for early diagnosis, prognosis and recognition of immunosuppression in sepsis. | Int Immunopharmacol | 2022 | 35272172 | PubTator, text mining | PubMed |
| AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer. | Int J Gen Med | 2022 | 35264871 | PubTator, text mining | PubMed |
| Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors. | Endocrinol Metab (Seoul) | 2022 | 35255603 | PubTator, text mining | PubMed |
| Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity. | Front Immunol | 2022 | 35251023 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease. | Front Immunol | 2022 | 35250976 | PubTator, text mining | PubMed |
| Full genomic sequence of the HLA-DPA1*02:46 allele identified by next generation sequencing. | HLA | 2022 | 35246963 | PubTator, text mining | PubMed |
| Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules. | Sci Adv | 2022 | 35245125 | PubTator, text mining | PubMed |
| Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells. | Sci Immunol | 2022 | 35245086 | PubTator, text mining | PubMed |
| Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes. | Nat Commun | 2022 | 35241690 | PubTator, text mining | PubMed |
| LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. | Hereditas | 2022 | 35241179 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic analysis shows disturbed calcium homeostasis and deregulation of T lymphocyte apoptosis in inclusion body myositis. | J Neurol | 2022 | 35237874 | PubTator, text mining | PubMed |
| A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates. | J Clin Transl Hepatol | 2022 | 35233377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=48